Neutrophil-endothelial interactions and barrier function in sepsis
脓毒症中中性粒细胞-内皮相互作用和屏障功能
基本信息
- 批准号:8799334
- 负责人:
- 金额:$ 78.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-15 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdhesionsAdrenal Cortex HormonesAdultApicalAuthorshipBasement membraneBiochemicalBiologicalBlood PlateletsBlood VesselsBrainCell CommunicationCell SurvivalCellsCellular biologyChildChronicCritical CareDataDepositionDimensionsEndothelial CellsEndotheliumEventExtravasationFailureFunctional disorderFundingGlycocalyxHomeostasisHost DefenseHumanIndividualInfectionInfiltrationInflammationInflammatoryInflammatory ResponseInjuryIntegrin alpha3beta1IntegrinsInterventionKidneyLaboratoriesLeadLeukocytesLiverLungMeasuresMediatingMembraneModelingMolecularMorbidity - disease rateMusNeutrophil InfiltrationOrganOrgan failurePathogenesisPatientsPenetrationPermeabilityPhenotypePhysiologicalPlant RootsPlasma CellsPrincipal InvestigatorProcessRegulationResearch PersonnelRoleSepsisSideSpleenStimulusStretchingSubendothelial LayerSystemTestingTherapeuticTimeTissuesVascular EndotheliumVascular Permeabilitiesbody systemcell growthcombinatorialdesignexperienceinsightmigrationmonolayermortalityneutrophilnew therapeutic targetnovelphysical propertyresponsesealseptic
项目摘要
DESCRIPTION (provided by applicant): Sepsis continues to be a leading cause of mortality in the ICU. The root cause of mortality can be traced directly to multisystem organ failure caused by damage to the vasculature that supplies these organs. Vascular damage is due in part to uncontrolled leukocyte interaction with endothelium. The challenge in designing an immuno-centric intervention is to avoid complete suppression. In spite of systemic hyper-inflammation, trials using corticosteroids have failed. A more targeted and deliberate approach is needed. A common feature of the exaggerated inflammatory response during sepsis is the accumulation of activated neutrophils within the microvasculature of organs such as liver, kidney, brain, spleen and lung leading to cell mediated tissue damage and organ failure. The underlying mechanisms that lead to the accumulation of neutrophils in the vasculature with ensuing damage to barrier function are not known. The overarching hypothesis is that protection of the vascular endothelium from the damage induced by the activated neutrophils will facilitate a return to vascular homeostasis and in turn protect the parenchyma from an excessive invasive inflammatory response. We will (1) determine the mechanisms by which the endothelial glycocalyx layer regulates neutrophil-endothelial cell interaction during sepsis, (2) investigate whether neutrophil-derived microparticles protect endothelial barrier function, and (3) investigate
whether neutrophil diapedesis contributes to damage of the vascular basement membrane and is associated vascular permeability due to a loss of barrier function. If transmigration and degranulatory activities of neutrophils were controlled without being obviated, a more physiological response to infection/injury would ensue. Thus, understanding how to control vascular damage through manipulation of neutrophil extravasation has potential applications in many acute/chronic inflammatory settings including sepsis.
描述(由申请人提供):败血症仍然是ICU死亡率的主要原因。死亡率的根本原因可以直接追溯到由供应这些器官的脉管系统损坏引起的多系统器官故障。血管损伤部分是由于与内皮的不受控制的白细胞相互作用。设计以免疫为中心的干预措施的挑战是避免完全抑制。尽管有全身性高炎症,但使用皮质类固醇的试验仍失败了。需要采取更有针对性和故意的方法。败血症期间夸张的炎症反应的一个共同特征是肝脏,肾脏,脑,脑,脾脏和肺等器官微举行的中性粒细胞的积累,导致细胞介导的组织损伤和器官衰竭。尚不清楚导致中性粒细胞在脉管系统中积累并随之而来的屏障功能损害的基本机制。总体假设是,保护血管内皮免受激活中性粒细胞造成的损害的保护将有助于恢复血管稳态,进而保护实质免受过度浸润性炎症反应。我们将(1)确定内皮糖脂层调节败血症期间中性粒细胞 - 内皮细胞相互作用的机制,(2)研究中性粒细胞衍生的微粒是否保护内皮屏障功能,以及(3)研究(3)
中性粒细胞二尿作用是否有助于血管基底膜的损害,并且由于屏障功能的丧失而与血管渗透性相关。如果控制中性粒细胞的迁移和递增活性而没有被消除,则会对感染/损伤产生更生理的反应。因此,了解如何通过操纵中性粒细胞渗出来控制血管损伤具有潜在的应用在包括败血症在内的许多急性/慢性炎症环境中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Minsoo Kim其他文献
Minsoo Kim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Minsoo Kim', 18)}}的其他基金
Complement C1q and sepsis associated fatalities
补充 C1q 和脓毒症相关死亡
- 批准号:
10515703 - 财政年份:2022
- 资助金额:
$ 78.63万 - 项目类别:
Complement C1q and sepsis associated fatalities
补充 C1q 和脓毒症相关死亡
- 批准号:
10643889 - 财政年份:2022
- 资助金额:
$ 78.63万 - 项目类别:
Complement C1q and sepsis associated fatalities
补充 C1q 和脓毒症相关死亡
- 批准号:
10832821 - 财政年份:2022
- 资助金额:
$ 78.63万 - 项目类别:
Functional genomic investigation of complement signaling in the human brain
人脑补体信号传导的功能基因组研究
- 批准号:
10389218 - 财政年份:2021
- 资助金额:
$ 78.63万 - 项目类别:
Visualizing the resolution of innate immune responses during influenza infection
可视化流感感染期间先天免疫反应的解决
- 批准号:
10084273 - 财政年份:2020
- 资助金额:
$ 78.63万 - 项目类别:
Visualizing the resolution of innate immune responses during influenza infection
可视化流感感染期间先天免疫反应的解决
- 批准号:
9899365 - 财政年份:2020
- 资助金额:
$ 78.63万 - 项目类别:
Identification of a Damaging Subset of Neutrophils that Arises in Septic Patients
脓毒症患者中出现的破坏性中性粒细胞亚群的鉴定
- 批准号:
10179456 - 财政年份:2019
- 资助金额:
$ 78.63万 - 项目类别:
T cell migration and cardiovascular toxicity in immunotherapy
免疫治疗中的 T 细胞迁移和心血管毒性
- 批准号:
10646491 - 财政年份:2019
- 资助金额:
$ 78.63万 - 项目类别:
T cell migration and cardiovascular toxicity in immunotherapy
免疫治疗中的 T 细胞迁移和心血管毒性
- 批准号:
9981638 - 财政年份:2019
- 资助金额:
$ 78.63万 - 项目类别:
相似国自然基金
促细胞外囊泡分泌的绒毛膜纳米纤维仿生培养体系的构建及其在宫腔粘连修复中的应用研究
- 批准号:32301204
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
载Pexidartinib的纳米纤维膜通过阻断CSF-1/CSF-1R通路抑制巨噬细胞活性预防心脏术后粘连的研究
- 批准号:82370515
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
泛素连接酶SMURF2通过SMAD6-COL5A2轴调控宫腔粘连纤维化的分子机制研究
- 批准号:82360301
- 批准年份:2023
- 资助金额:31 万元
- 项目类别:地区科学基金项目
负载羟基喜树碱的双层静电纺纳米纤维膜抑制肌腱粘连组织增生的作用和相关机制研究
- 批准号:82302691
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
活血通腑方调控NETs干预术后腹腔粘连组织纤维化新途径研究
- 批准号:82374466
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Mitigation of Exaggerated Smooth Muscle Force with Inhibitors of Integrin Alpha2Beta1
使用整合素 Alpha2Beta1 抑制剂缓解过度的平滑肌力
- 批准号:
10448088 - 财政年份:2022
- 资助金额:
$ 78.63万 - 项目类别:
Mitigation of Exaggerated Smooth Muscle Force with Inhibitors of Integrin Alpha2Beta1
使用整合素 Alpha2Beta1 抑制剂缓解过度的平滑肌力
- 批准号:
10629319 - 财政年份:2022
- 资助金额:
$ 78.63万 - 项目类别:
Epithelial control of responses to allergen challenge and viral exacerbation
上皮细胞对过敏原挑战和病毒恶化反应的控制
- 批准号:
10168800 - 财政年份:2020
- 资助金额:
$ 78.63万 - 项目类别:
Epithelial control of responses to allergen challenge and viral exacerbation
上皮细胞对过敏原挑战和病毒恶化反应的控制
- 批准号:
9157669 - 财政年份:2016
- 资助金额:
$ 78.63万 - 项目类别:
Epithelial control of responses to allergen challenge and viral exacerbation
上皮细胞对过敏原挑战和病毒恶化反应的控制
- 批准号:
9315099 - 财政年份:2016
- 资助金额:
$ 78.63万 - 项目类别: